MRI enters into a strategic alliance
Metabolic Research, Inc. has entered into a strategic alliance with Cornerstone Pharmaceuticals.
Metabolic Research, Inc. (MTBR) is a biotechnology company that produces and markets proprietary nutraceuticals. MTBR has developed a proprietary blend of mushrooms that are custom grown as a key component of its Wellness and Sports Nutrition product, Stemulite™ Fitness Formula. Affirming its commitment of providing all natural, pharmaceutical-grade, non-synthetic dietary supplements to safely and effectively support and enhance numerous body systems, MTBR's Fitness Formula promotes increases in strength, muscle, energy, endurance, REM sleep and the speed of exercise recovery.
MTBR's primary mission is to support optimum Quality of Life with natural products promoting enhanced fitness and wellness.
Our products embody significant unique features:
Metabolic Research, Inc's flagship products, Stemulite™ Fitness Formula for Men and Stemulite™ Fitness Formula for Women, were developed for fitness and wellness utilizing, among other mechanisms; adult stem cell recruitment in conjunction with circadian body rhythms differentiated between waking and sleeping states. The circadian formulas are combined with essential nutrients and fatty acids that regulate the metabolic processes of mitochondrial gene expression, growth factors and protein synthesis.
New Product Research and Development
In keeping with its mission to support fitness, health and wellness through pharmaceutical grade nutraceuticals, Metabolic Research, Inc. is currently developing several new products targeting specific and financially viable consumer demographics exhibiting strong propensities to purchase and consume such products. Developed in concert with Cornerstone Pharmaceuticals, these new products utilize cutting edge delivery systems for maximum integration into the body at a cellular level. MTBR's new product initiatives are strategically designed for effectiveness, marketplace desirability, and broad-based consumer acceptance.